Skip to main content

Xchanging reveals £500m IPO price

Xchanging has announced the offer price for its IPO has been set at 240 pence per ordinary share. This gives a market capitalisation of approximately £493m and a diluted equity value of approximately £525m.

Following a roadshow to investors in the UK, US and Continental Europe, the ordinary shares have been placed with a broad range of institutional shareholders. The order book was many times subscribed

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Diary of an Insurer: Rokstone’s Darren Guymer

Darren Guymer was hired as head of surety at Rokstone in June 2025. His working week sees him take a hands-on approach to building relationships with both carriers and brokers while also coaching his son’s under eight’s football team.

Q&A: Will Pritchett, Accenture UK and Ireland

Will Pritchett, insurance lead for Accenture UK and Ireland, talks to Insurance Post about how insurers can cope with changing demands as AI transforms the industry, and how the company’s role in supporting providers is evolving.

Axa aims to double schemes business

Sarah Mallaby, chief distribution officer and mid-market trading director at Axa Commercial, has revealed the provider is looking to double its schemes business as the firm looks to become a “£2bn business”.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here